Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in Mainland France between 1996 and 2003

Archives of Pediatrics and Adolescent Medicine

Volumn 166, Issue 2, 2012, Pages 113-120

  Coulm, Bénédicte ^a   Coste, Joel ^a   Tardy, Veŕonique ^b   Ecosse, Emmanuel ^a   Roussey, Michel ^c,d   Morel, Yves ^b   Carel, Jean Claude ^e  

^a University Paris Descartes ^*  (France)

^b HOSPICES CIVILS DE LYON   (France)

^c AFDPHE   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; DISEASE SEVERITY; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; FRANCE; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN MORTALITY; NEWBORN SCREENING; PRIORITY JOURNAL; SALT WASTING; STEROID 21 MONOOXYGENASE DEFICIENCY;

ADRENAL HYPERPLASIA, CONGENITAL; FALSE POSITIVE REACTIONS; FEMALE; FRANCE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LINEAR MODELS; MALE; NEONATAL SCREENING; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84856735747     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2011.774     Document Type: Article

References (26)

1. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245-291. (Pubitemid 32275589)
2. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365(9477):2125-2136. (Pubitemid 40826971)
3. Speiser PW, Azziz R, Baskin LS, et al Endocrine Society. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133-4160.
4. Johannsen TH, Mallet D, Dige-Petersen H, et al. Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3β-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 2005;90(4):2076-2080. (Pubitemid 40586242)
5. Pang SY, Wallace MA, Hofman L, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 1988;81(6):866-874.
6. Wilson JM. The evaluation of the worth of early disease detection. J R Coll Gen Pract. 1968;16(suppl 2):48-57.
7. Grosse SD, Van Vliet G. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? Horm Res. 2007;67(6):284-291. (Pubitemid 46701493)
8. National newborn screening and genetics resource center. http://ghr.nlm.nih.gov/nbs. Accessed March 8, 2011.
9. Loeber JG. Neonatal screening in Europe; the situation in 2004. J Inherit Metab Dis. 2007;30(4):430-438. (Pubitemid 47377038)
10. Janzen N, Peter M, Sander S, et al. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2007;92(7):2581-2589. (Pubitemid 47037361)
11. Cartigny-Maciejewski M, Guilley N, Vanderbecken S, et al. Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980-1996 [in French]. Arch Pediatr. 1999;6(2):151-158. (Pubitemid 29535508)
12. Dhondt JL, Farriaux JP. The wonderful history of neonatal screening. Ann Biol Clin (Paris). 2000;58(3):267-276.
13. Morel Y, Miller WL. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In: Harris H, Hirschhorn K, eds. Advances in Human Genetics. 20th ed. New York, NY: Plenum Press; 1991:1-68.
14. Tardy V, Menassa R, Sulmont V, et al. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier. J Clin Endocrinol Metab. 2010;95(3):1288-1300.
15. van Dommelen P, van Wouwe JP, Breuning-Boers JM, van Buuren S, Verkerk PH. Reference chart for relative weight change to detect hypernatraemic dehydration. Arch Dis Child. 2007;92(6):490-494. (Pubitemid 46867263)
16. Blondel B, Supernant K, Du Mazaubrun C, Bréart G; pour la Coordination nationale des Enquêtes Nationales Périnatales. Trends in perinatal health in metropolitan France between 1995 and 2003: results from the National Perinatal Surveys [in French]. J Gynecol Obstet Biol Reprod (Paris). 2006;35(4):373-387. (Pubitemid 43873121)
17. Therrell BLJ, Berenbaum SA, Manter-Kapanke V, et al. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics. 1998;101(4, pt 1):583-590. (Pubitemid 28180138)
18. Steigert M, Schoenle EJ, Biason-Lauber A, Torresani T. High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. J Clin Endocrinol Metab. 2002;87(9):4106-4110.
19. Van der Kamp HJ, Noordam K, Elvers B, Van Baarle M, Otten BJ, Verkerk PH. Newborn screening for congenital adrenal hyperplasia in theNetherlands. Pediatrics. 2001;108(6):1320-1324. (Pubitemid 33121474)
20. Balsamo A, Cacciari E, Piazzi S, et al. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995. Pediatrics. 1996;98(3, pt 1):362-367. (Pubitemid 26295835)
21. Nordenstrom A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics. 2001;108(4):e68. doi:10.1542/peds.108.4.e68.
22. Wong T, Shackleton CH, Covey TR, Ellis G. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clin Chem. 1992;38(9):1830-1837.
23. al Saedi S, Dean H, Dent W, Cronin C. Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. J Pediatr. 1995;126(6):985-987.
24. Minutti CZ, Lacey JM, Magera MJ, et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2004;89(8):3687-3693. (Pubitemid 39071456)
25. Kovács J, Votava F, Heinze G, et al Middle European Workshop on Paediatric Endocrinology-Congenital Adrenal Hyperplasia Study Group. Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab. 2001;86(7):2958-2964. (Pubitemid 32673448)
26. Yoo BK, Grosse SD. The cost effectiveness of screening newborns for congenital adrenal hyperplasia. Public Health Genomics. 2009;12(2):67-72.